Collagen Solutions PLC (LON:COS) has been reiterated to Buy in a statement by Panmure Gordon earlier today.
- Updated: October 15, 2016
Only yesterday Collagen Solutions PLC (LON:COS) traded -6.45% lower at 7.75GBX. The company’s 50-day moving average is 8.21GBX and its 200-day moving average is 7.28GBX. The last stock price is up -0.34% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the date range. Volume of trade was down over the average, with 55,000 shares of COS changing hands under the typical 109,882
Panmure Gordon has reiterated Collagen Solutions PLC (LON:COS) to Buy in a report released on 10/13/2016.
On 9/15/2016, Panmure Gordon released a statement on Collagen Solutions PLC (LON:COS) held steady the target price at 10.00GBX. At the time, this indicated a possible upside of 0.16%.
With a market cap of 0 GBX, Collagen Solutions PLC has 52 week low of 5.00GBX and a 52 week high of 11.12GBX .
In addition to Panmure Gordon reporting its stock price target, a total of 1 broker has issued a report on the stock. The 12-month price target is 10.00GBX with 0 brokerages rating the stock a strong buy, one analyst rating the company a buy, 0 firms rating the stock a hold, zero equity analysts rating the company a underperform, and finally 0 brokers rating the company a sell.
More About Collagen Solutions PLC (LON:COS)
Collagen Solutions plc is a holding company. The Company is engaged in the business of supply, development and manufacture of medical grade collagen components and biomaterials. The Company's products and services are utilized in the research, diagnostics, medical devices and regenerative medicine markets. The Company's main products include Collagen and tissue biomaterials. The Company's product range includes raw tissue supply, including pericardium, which is used in heart valves and dural patches, various strengths of soluble and acid soluble collagen, acid swollen gels, freeze-dried powders, collagen sheets and fibrous collagen. The Company also manufactures Excellagen, a collagen gel used in wound care and cell therapy fields. Its services include product development and contract manufacturing. It offers a range of bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications, including bone, cartilage and tendon, and veins and blood vessels.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.